Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Davidstea Inc is a packaged foods business based in the US. Davidstea shares (DTEA) are listed on the NASDAQ and all prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $1.83 |
|---|---|
| 52-week range | $1.63 - $4.69 |
| 50-day moving average | $2.13 |
| 200-day moving average | $2.96 |
| Wall St. target price | $3.48 |
| PE ratio | 0.8808 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $2.06 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.825 from 2022-06-28
| 1 week (2022-06-23) | -0.27% |
|---|---|
| 1 month (2022-05-27) | -4.45% |
| 3 months (2022-03-28) | -37.29% |
| 6 months (2021-12-30) | -40.55% |
| 1 year (2021-06-30) | -58.05% |
|---|---|
| 2 years (2020-06-30) | 90.10% |
| 3 years (2019-06-28) | 40.38% |
| 5 years (2017-06-29) | 5.7038 |
Valuing Davidstea stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Davidstea's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Davidstea's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Davidstea shares trade at around 1x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Davidstea's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.6 million.
The EBITDA is a measure of a Davidstea's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $101.3 million |
|---|---|
| Gross profit TTM | $43.2 million |
| Return on assets TTM | -5.09% |
| Return on equity TTM | 74.87% |
| Profit margin | 72.03% |
| Book value | $1.77 |
| Market capitalisation | $47.9 million |
TTM: trailing 12 months
We're not expecting Davidstea to pay a dividend over the next 12 months.
Over the last 12 months, Davidstea's shares have ranged in value from as little as $1.63 up to $4.69. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Davidstea's is 3.0762. This would suggest that Davidstea's shares are significantly more volatile than the average for this exchange and represent a higher risk.
DAVIDsTEA Inc. operates as a specialty tea retailer in Canada and the United States. It offers loose-leaf teas, pre-packaged teas, tea sachets, and tea-related gifts; tea accessories, including tea mugs, travel mugs, teacup sets, teapots, tea makers, kettles, infusers, filters, frothers, tins, and spoons; and food and beverages. As of April 29, 2022, it operated through 18 company-owned stores. The company also provides its products its e-commerce platform, davidstea. com; and distributes products through 3,500 grocery stores and pharmacies. DAVIDsTEA Inc.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
